TETON-2 Findings in Treatment of Idiopathic Pulmonary Fibrosis #podcast #raredisease @checkrare
TETON-2 Findings in Treatment of Idiopathic Pulmonary Fibrosis #podcast #raredisease  @checkrare
Uploaded November 2026 | Updated November 2026, 4 hours ago
Steven Nathan, MD, MBBCh, FCCP, Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital, discusses findings from a post-hoc analysis of the phase 3 TETON-2 study, presented at the CHEST 2026 Annual Meeting.

View the full interview at checkrare.com/inhaled-treprostinil-reduces-multiple-disease-progression-events-in-ipf
TETON-2 Findings in Treatment of Idiopathic Pulmonary Fibrosis #podcast #rarediseaseCongenital Adrenal Hyperplasia: Effect of Crenessity (Crinecerfont) on Bone Age AdvancementEfficacy of Infigratinib on AchondroplasiaMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseInvestigating Results From the MAVORIC Trial in Patients With CTCLMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisUCB Study Highlights the Burden of Ocular Myasthenia GravisGambling on Clinical TrialsMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisNarcolepsy Awareness MonthFirst-Line Therapy Approved for Rare Lung Cancer  
CheckRare |

TETON-2 Findings in Treatment of Idiopathic Pulmonary Fibrosis #podcast #raredisease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER